This site is intended for Healthcare Professionals only.

Tag: incontinence; overactive bladder syndrome;

spot_imgspot_img

MHRA approves two new medicines for overactive bladder syndrome and breast cancer

Pierre Fabre Limited receives MHRA marketing authorisation for vibegron, Astra Zeneca UK Limited for Capivasertib  The Medicines and Healthcare products Regulatory Agency (MHRA) on Thursday,...

Dr. Reddy’s Teraleve® Fesoterodine Fumarate Prolonged-Release tablets for incontinence

Dr. Reddy’s Teraleve ® 4mg and 8mg Fesoterodine Fumarate Prolonged-Release tablets have been available in the UK since their launch on 1st June 2022. Therapeutic...